Meet our Team
MentorTech Ventures is led by a team of Penn alumni with decades of early stage investing and operating experience.
Michael B. Aronson | Managing Director
Mr. Aronson co-founded MentorTech and has had a more than 30 year career working with technology companies. He has significant expertise in company formation around business school concepts, software development, capital raising, strategic alliances and joint ventures, financial reporting and tax issues, executive compensation, employment matters and copyright law. He represents MentorTech on the Board of The Neat Company, Ticketleap, Soft Tissue Regeneration , SeniorHomes.com, Innova Dynamics, EyeIC, DietTV and NeuroDiagnostic Devices. He serves as a Board Observer at Bioconnect, Gentis, Kembrel and Medivo and served at Wanderfly prior to their acquisition. He acted as an advisor to management at Merchant Circle, Yodle, and Diapers.com.
Prior to becoming a full time venture capitalist, he was an entrepreneur and angel investor. Mr. Aronson was the co-founder, CFO, EVP & Board Member of SMG, Inc., a $28M simulation software company, named three times to “Inc. 500” fastest growing companies list. He was a founding shareholder and/or co-founder of five successful software companies, two of which were acquired by public entities, two by private investors and one of which has NYSE-listed corporate investor. He was also an investor in two additional software companies, one of which was acquired by public company and one which had successful IPO.
In addition to his work with MentorTech and his entrepreneurial activities, Mr. Aronson has served on the Board, and the Executive and Investment Committees of Ben Franklin Technology Partners of Southeastern Pennsylvania for more than 20 years. He also served as a Senior Lecturer and faculty member at Wharton for 20 years and has a network of more than 4,000 former students.
Mr. Aronson received his B.S. in Economics with Honor from the Wharton School of the University of Pennsylvania in 1978, majoring in Entrepreneurial Management and Multinational Enterprise.
Boris Kalandar | Managing Director
Mr. Kalandar is a co-founder of MentorTech and has 20 years experience in business development, venture capital, M&A, and management consulting. Prior to becoming a full time venture capitalist, he co-founded 3 successful technology companies. He has also completed a number of acquisitions, management turnarounds and exits. He presently represents MentorTech on the Board of Directors of Molecular Detection, Inc., EyeIC and NeuroDiagnostic Devices. He is also a Board member of Rainbow Medical, Ltd. (Israel).
He is also the founder of SVM Advisors, LLC, a 20 year old boutique technology merchant bank. SVM has raised over $100 million for portfolio companies and other venture funds. Mr. Kalandar is also a former senior executive with SMG, Inc, which was named three times to “Inc. 500” fastest growing companies list. He led the $50 million private equity re-capitalization exit for the company. He started his venture capital investment experience at Safeguard Scientifics (NYSE: SFE), a public venture capital holding company, where he was with the first early stage venture capital fund sponsored by Safeguard.
For the last 13 years, he has served on the Investment Advisory Committee of Ben Franklin Technology Partners of Southeast Pennsylvania.
Mr. Kalandar received his MBA in Finance and Strategic Planning from the Wharton School, and his MSEE from the Institute of Electrical Engineering in St. Petersburg, Russia
Brett Topche | Managing Director
Mr. Topche joined MentorTech Ventures in 2007 and has more than a decade of venture capital and private equity experience. He has spent much of his career primarily focusing on investments in ecommerce, digital media, mobile applications, marketing technologies and B2B software. He represents MentorTech on the Boards of Directors of PayPerks and Kembrel and served on the Board of Wanderfly prior to its acquisition. He also serves as a Board Observer at Curalate, Cloudmine, SeniorHomes.com, Soft Tissue Regeneration and TicketLeap and as a member of the Investor Advisory Board of SnipSnap.
Prior to joining MentorTech, he was a member of the Fund Investments Team at Hamilton Lane Advisors, a fund-of-funds manager and private equity investment consultant. In this capacity, he evaluated private equity funds across a broad spectrum of stages and strategies on behalf of both discretionary and non-discretionary clients. During his time at Hamilton Lane, Mr. Topche reviewed more than 100 funds, including venture capital, mezzanine, buyout and real estate funds. Based in part on reports he drafted, more than $1 billion was invested into these funds.
Prior to working for Hamilton Lane, Mr. Topche spent more than four years as an Associate with NJTC Venture Fund, where he focused on investments in early-stage companies in the software, Internet and communications sectors. His responsibilities included deal flow generation, initial company reviews, performing due diligence on potential investments, participating in deal structuring, reviewing legal documentation and working with companies post-investment, occasionally as an Observer on Boards of Directors.
Mr. Topche is a magna cum laude graduate of the Wharton School, with a B.S. in Economics, with concentrations in Finance and Legal Studies and a Political Science minor from the College and Arts and Sciences.
Marshall Yang | Analyst
Marshall Yang joined MentorTech in 2012 as an analyst. He was previously an analyst at Robin Hood Ventures, one of the largest early-stage investors in the Philadelphia region. At Robin Hood, Marshall invested in software and internet companies, and built relationships with entrepreneurs and investors by sponsoring and co-hosting Philly Tech Meetup. Marshall is also a business development consultant for a Global 500 company, advising the corporation’s fintech and mobile innovations.
Prior to Robin Hood Ventures, Marshall interned at LB investments in Shanghai, the VC arm of LG Group, where he invested in e-commerce, mobile, and internet companies. He was also a consultant to NewSpring Capital, where he developed investment theses facing the changes brought by the Affordable Care Act.
Prior to his business career, Marshall interned at Merck as an automation engineer, where he developed in-house software-as-a-service, streamlining the drug discovery process. Later, he and his colleagues at Merck founded Lab Informant, a software company in the biotech space. Lab Informant was selected as a DreamIt Ventures Finalist.
Marshall has an M.S.E. in Bioengineering from the University of Pennsylvania, where he did research and published in the field of computational simulation. He was also a winger in the Wharton Wildmen Hockey League, and won the 2011-12 Championship with his team. He blogs at www.marshallyang.com.